{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:03:24Z","timestamp":1784898204852,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00120-026-02869-6","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:47:39Z","timestamp":1781596059000},"page":"879-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Androgendeprivation bei definitiver Radiotherapie des lokalisierten Prostatakarzinoms: Was ist die optimale Therapiedauer?","Androgen deprivation with definitive radiotherapy for localized prostate cancer: what is the optimal treatment duration?"],"prefix":"10.1007","volume":"65","author":[{"given":"Henning","family":"Plage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Stangl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"2869_CR1","unstructured":"(2025) Krebsregisterdaten zum Prostatakrebs. https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Krebsarten\/Prostatakrebs\/prostatakrebs_node.html. Zugegriffen: 19. Mai 2026"},{"key":"2869_CR2","unstructured":"Leitlinienprogramm Onkologie (2025) S3-Leitlinie Prostatakarzinom, Version 8.1 - August 2025."},{"issue":"10323","key":"2869_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(21)02437-5","volume":"399","author":"G Attard","year":"2022","unstructured":"Attard\u00a0G et\u00a0al (2022) Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a\u00a0meta-analysis of primary results from two randomised controlled phase\u00a03\u00a0trials of the STAMPEDE platform protocol. Lancet 399(10323):447\u2013460","journal-title":"Lancet"},{"issue":"16","key":"2869_CR4","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2025.0228","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri\u00a0R, Lin\u00a0DW, Montgomery\u00a0RB (2025) Prostate Cancer: A Review. JAMA 333(16):1433\u20131446","journal-title":"JAMA"},{"issue":"2","key":"2869_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1470-2045(21)00705-1","volume":"23","author":"AU Kishan","year":"2022","unstructured":"Kishan\u00a0AU et\u00a0al (2022) Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis. Lancet Oncol 23(2):304\u2013316","journal-title":"Lancet Oncol"},{"issue":"1","key":"2869_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2022.04.003","volume":"82","author":"AU Kishan","year":"2022","unstructured":"Kishan\u00a0AU et\u00a0al (2022) High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol 82(1):106\u2013114","journal-title":"Eur Urol"},{"issue":"28","key":"2869_CR7","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1200\/JCO-25-00274","volume":"43","author":"K Menne Guricov\u00e1","year":"2025","unstructured":"Menne Guricov\u00e1\u00a0K et\u00a0al (2025) Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial. J\u00a0Clin Oncol 43(28):3065\u20133069","journal-title":"J Clin Oncol"},{"issue":"3","key":"2869_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1470-2045(25)00656-4","volume":"27","author":"P Nilsson","year":"2026","unstructured":"Nilsson\u00a0P et\u00a0al (2026) Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol 27(3):293\u2013301","journal-title":"Lancet Oncol"}],"updated-by":[{"DOI":"10.1007\/s00120-026-02897-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000}}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-026-02869-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:19:26Z","timestamp":1784895566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-026-02869-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2869"],"URL":"https:\/\/doi.org\/10.1007\/s00120-026-02869-6","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"2 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zu diesem Beitrag wurde ein Erratum ver\u00f6ffentlicht:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00120-026-02897-2","URL":"https:\/\/doi.org\/10.1007\/s00120-026-02897-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.\u00a0Plage und F.\u00a0Stangl geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}